Skip to main content
Log in

Effect of tonsillectomy and its timing on renal outcomes in Caucasian IgA nephropathy patients

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

The role of tonsillectomy in the treatment of IgA nephropathy in Caucasian patients is controversial.

Methods

A retrospective cohort study was conducted in 264 patients with biopsy-proven primary IgA nephropathy to examine the association between tonsillectomy and long-term renal survival, defined as the incidence of estimated glomerular filtration rates (eGFRs) of ≤30 ml/min/1.73 m2 or end-stage renal disease (the composite of initiation of dialysis treatment or renal transplantation). The association of tonsillectomy with renal end-points was examined using the Kaplan–Meier method and Cox models.

Results

One-hundred and sixty-six patients did not undergo tonsillectomy (Group I, follow-up 130 ± 101 months) and 98 patients underwent tonsillectomy (Group II, follow-up 170 ± 124 months). The mean renal survival time was significantly longer for both end-points between those patients who underwent tonsillectomy (Group II) versus patients without tonsillectomy (Group I) (p < 0.001 and p = 0.005). The mean renal survival time was significantly longer for both end-points between those patients who had macrohaematuric episodes versus patients who had no macrohaematuric episodes (p = 0.035 and p = 0.019). Tonsillectomy, baseline eGFR and 24-h proteinuria were independent risk factors for both renal end-points.

Conclusion

Tonsillectomy may delay the progression of IgA nephropathy mainly in IgA nephropathy patients with macrohaematuria. Prospective investigation of the protective role of tonsillectomy in Caucasian patients is needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Schena FP, Pesce F (2009) Epidemiology and ancestral difference. In: Lai KN (ed) Recent advances in IgA nephropathy. World Scientific Publishing Co., New Jersey, pp 9–20

    Chapter  Google Scholar 

  2. Feehally J, Floege J (2010) IgA nephropathy and Henoch-Schönlein nephritis. In: Floege J, Johnson RJ, Feehally F (eds) Comprehensive clinical nephrology, 4th edn. Elsevier, Amsterdam, pp 270–281

    Chapter  Google Scholar 

  3. Wyatt RJ, Julian BA (2013) IgA nephropathy. N Engl J Med 368:2402–2414

    Article  PubMed  CAS  Google Scholar 

  4. Berthoux FC, Mohey H, Afiani A (2008) Natural history of primary IgA nephropathy. Semin Nephrol 28:4–9

    Article  PubMed  Google Scholar 

  5. D’Amico G, Imbasciati E, Barbiano DI et al (1985) Idiopathic IgA mesangial nephropathy. Clinical and histological study of 374 patients. Medicine (Baltimore) 64:49–60

    Google Scholar 

  6. Suzuki H, Kiryluk K, Novak J et al (2011) The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22:1795–1803

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  7. Boyd JK, Cheung CK, Molyneux K et al (2012) An update on the pathogenesis and treatment of IgA nephropathy. Kidney Int 81:833–843

    Article  PubMed  CAS  Google Scholar 

  8. Lai KN (2012) Pathogenesis of IgA nephropathy. Nat Rev Nephrol 8:275–283

    Article  PubMed  CAS  Google Scholar 

  9. Barrat J, Feehally J (2011) Primary IgA nephropathy: new insight into pathogenesis. Semin Nephrol 31:349–360

    Article  Google Scholar 

  10. Floege J (2011) The pathogenesis of IgA nephropathy: What is new and how does it change therapeutic approaches? Am J Kidney Dis 58:992–1004

    Article  PubMed  CAS  Google Scholar 

  11. Hiki Y, Ito A, Yamamoto Y et al (2011) IgA nephropathy and aberrant glycosylation of tonsillar, serum and glomerular IgA1. Adv Otorhinolaryngol 72:68–70

    PubMed  Google Scholar 

  12. Glassock RJ (2011) The pathogenesis of IgA nephropathy. Curr Opin Nephrol Hypertens 20:153–160

    Article  PubMed  CAS  Google Scholar 

  13. Rifai A, Fadden K, Morrison SL et al (2000) The N- glycans determine the differential blood clearance and hepatic uptake of human immunologlobulin (Ig)A1 and IgA2 isotypes. J Exp Med 191:2171–2181

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  14. Matsuzaki K, Suzuki Y, Nakata J et al (2013) Nationwide survey on current treatments for IgA nephropathy in Japan.Clin Exp Nephrol. doi:10.1007/s10157-013-0779-7

  15. Wang Y, Chen J, Wang Y et al (2011) A meta-analysis of the clinical remission rate and long-term efficacy of tonsillectomy in patients with IgA nephropathy. Nephrol Dial Transplant 26:1923–1931

    Article  PubMed  CAS  Google Scholar 

  16. Rasche FM, Schwarz A, Keller F (1999) Tonsillectomy does not prevent a progressive course in IgA nephropathy. Clin Nephrol 51:4147–4152

    Google Scholar 

  17. Piccoli A, Codognoto M, Tabbi MG et al (2010) Influence of tonsillectomy on the progression of mesangioproliferative glomerulonephritis. Nephrol Dial Transplant 25:2583–2589

    Article  PubMed  Google Scholar 

  18. Ieiri N, Hotta O, Sato T, Taguma Y (2012) Significance of the duration of nephropathy for achieving clinical remission in patients with IgA nephropathy treated by tonsillectomy and steroid pulse therapy. Clin Exp Nephrol 16:122–129

    Article  PubMed  CAS  Google Scholar 

  19. Maeda I, Hayashi T, Sato KK et al (2012) Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy. Nephrol Dial Transplant 27:2806–2813

    Article  PubMed  Google Scholar 

  20. Nagy J, Brandtzaeg P (1988) Tonsillar distribution of IgA, IgG immunocytes and IgA subclasses in IgA nephropathy. Contrib Nephrol 67:107–110

    PubMed  CAS  Google Scholar 

  21. Nagy J, Brandtzaeg P (1988) Tonsillar distribution of IgA and IgG immunocytes and production of IgA subclasses and J chain in tonsillitis vary with the presence or absence of IgA nephropathy. Scand J Immunol 27:393–399

    Article  PubMed  CAS  Google Scholar 

  22. Barta J, Kovács T, Fazekas A et al (1996) Does tonsillectomy cause any change in long-term course of IgA nephropathy? (In Hungarian with English abstract). Orv Hetil 137:2903–2906

    PubMed  CAS  Google Scholar 

  23. Kovács T, Vas T, Barta J et al (2002) Tonsillectomy and the progression of IgA nephropathy. (In Hungarian with English abstract). Hyperton Nephrol 6:228–231

    Google Scholar 

  24. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39(suppl 1):S1–S266

    Google Scholar 

  25. Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kaplan EL, Meier P (1958) Nonparametric estimation for incomplete observation. J Am Stat Assoc 53:116–122

    Article  Google Scholar 

  27. Hotta O, Miyazaki M, Furuta T et al (2001) Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis 38:736–743

    Article  PubMed  CAS  Google Scholar 

  28. Akagi H, Kosaka M, Hattori K et al (2004) Long-term results of tonsillectomy as a treatment for IgA nephropathy. Acta Otolaryngol Suppl 555:38–42

    Article  PubMed  Google Scholar 

  29. Chen Y, Tang Z et al (2007) Long-term efficacy of tonsillectomy in Chinese patients with IgA nephropathy. Am J Nephrol 27:170–175

    Article  PubMed  Google Scholar 

  30. Miyazaki M, Hotta O, Komatsuda A et al (2007) Japanese Multicenter Study Group on treatment of IgA nephropathy (JST-IgAN). A multicenter prospective cohort study of tonsillectomy and steroid pulse therapy in Japanese patients with IgA nephropathy: a 5-year report. Contrib Nephrol 157:94–98

    PubMed  CAS  Google Scholar 

  31. Komatsu H, Fujimoto S, Hara S et al (2008) Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. Clin J Am Soc Nephrol 3:1301–1307

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  32. Ohya M, Otani H, Minami Y et al (2013) Tonsillectomy with steroid pulse therapy has more effect on the relapse rate than steroid pulse monotherapy in IgA nephropathy patients. Clin Nephrol 80:47–52

    Article  PubMed  CAS  Google Scholar 

  33. Ochi A, Moriyama T, Takei T et al (2013) Comparison between steroid pulse therapy alone and in combination with tonsillectomy for IgA nephropathy. Int Urol Nephrol 45:469–476

    Article  PubMed  CAS  Google Scholar 

  34. Sato M, Hotta O, Tomioka S et al (2003) Cohort study of advanced IgA nephropathy: efficacy and limitations of corticosteroids with tonsillectomy. Nephron Clin Pract 93:c137–c145

    Article  PubMed  CAS  Google Scholar 

  35. Komatsu H, Fujimoto S, Kikuchi M et al (2012) Tonsillectomy delays progression of advanced IgA nephropathy to end-stage kidney disease. Ren Fail 34:448–453

    Article  PubMed  CAS  Google Scholar 

  36. Xie Y, Chen X, Nishi S et al (2004) Relationship between tonsils and IgA nephropathy as well as indications of tonsillectomy. Kidney Int 65:1135–1144

    Article  PubMed  CAS  Google Scholar 

  37. Nishi S, Xie Y, Ueno M et al (2004) A clinicopathological study on the long-term efficacy of tonsillectomy in patients with IgA nephropathy. Acta Otolaryngol Suppl 555:49–53

    Article  PubMed  Google Scholar 

  38. Nakagawa N, Kabara M, Matsuki M et al (2012) Retrospective comparison of the efficacy of tonsillectomy with and without steroid-pulse therapy in IgA nephropathy patients. Intern Med 51:1323–1328

    Article  PubMed  Google Scholar 

  39. Coppo R, Feehally J, Glassock JR (2010) IgA nephropathy at two score and one. Kidney Int 77:181–186

    Article  PubMed  CAS  Google Scholar 

  40. Ponticelli C (2012) Tonsillectomy and IgA nephritis. Nephrol Dial Transplant 27:2610–2613

    Article  PubMed  Google Scholar 

  41. Coppo R (2010) Can a dysregulated mucosal immune system in IgA nephropathy be controlled by tonsillectomy? Nephrol Dial Transplant 25:2395–2397

    Article  PubMed  CAS  Google Scholar 

  42. Bene MC, Faure GC, Harault de Ligny B et al (2004) Clinical involvement of the tonsillar immune system in IgA nephropathy. Acta Otolaryngol Suppl 555:10–14

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors are grateful for the advice of Prof. John Feehally during preparation of this manuscript. The study was supported by SROP-4.2.2/B-10/1/2010-0029 Supporting Scientific Training of Talented Youth at the University of Pécs. Dr Kovesdy is supported by grant 1R01DK096920-01 from the NIH/NIDDK. Dr. Kovesdy is an employee of the US Department of Veterans Affairs. Opinions expressed in this paper are those of the authors, and do not necessarily represent the opinion of the US Department of Veterans Affairs.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Judit Nagy.

Additional information

Tibor Kovács and Tibor Vas have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kovács, T., Vas, T., Kövesdy, C.P. et al. Effect of tonsillectomy and its timing on renal outcomes in Caucasian IgA nephropathy patients. Int Urol Nephrol 46, 2175–2182 (2014). https://doi.org/10.1007/s11255-014-0818-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-014-0818-7

Keywords

Navigation